tiprankstipranks
Trending News
More News >
Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
US Market
Advertisement

Harmony Biosciences Holdings (HRMY) Ratios

Compare
333 Followers

Harmony Biosciences Holdings Ratios

HRMY's free cash flow for Q2 2025 was $0.81. For the 2025 fiscal year, HRMY's free cash flow was decreased by $ and operating cash flow was $0.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.84 2.75 5.07 5.29 1.95
Quick Ratio
3.80 2.72 5.02 5.21 1.93
Cash Ratio
3.03 1.90 3.09 4.36 1.70
Solvency Ratio
0.61 0.44 0.76 0.22 -0.13
Operating Cash Flow Ratio
1.44 1.34 1.83 1.83 -0.02
Short-Term Operating Cash Flow Coverage
13.83 14.63 72.23 49.28 0.00
Net Current Asset Value
$ 356.43M$ 106.61M$ 129.25M$ 37.50M$ -67.00M
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.24 0.28 0.44 0.45
Debt-to-Equity Ratio
0.22 0.41 0.48 1.03 2.00
Debt-to-Capital Ratio
0.18 0.29 0.32 0.51 0.67
Long-Term Debt-to-Capital Ratio
0.17 0.28 0.32 0.50 0.67
Financial Leverage Ratio
1.43 1.74 1.67 2.32 4.39
Debt Service Coverage Ratio
9.00 4.57 12.47 3.99 -0.47
Interest Coverage Ratio
26.52 8.08 7.67 2.87 0.13
Debt to Market Cap
0.08 0.10 0.06 0.08 0.09
Interest Debt Per Share
3.14 3.65 3.50 3.75 3.91
Net Debt to EBITDA
-1.41 -0.53 -0.36 -0.40 -22.72
Profitability Margins
Gross Profit Margin
78.34%79.17%80.93%81.82%82.64%
EBIT Margin
31.22%33.87%27.45%20.17%10.63%
EBITDA Margin
34.31%38.06%32.79%34.82%0.95%
Operating Profit Margin
28.72%32.99%27.45%22.49%2.30%
Pretax Profit Margin
29.14%29.79%23.91%12.25%-23.13%
Net Profit Margin
23.42%22.14%41.44%11.33%-32.46%
Continuous Operations Profit Margin
23.42%22.14%41.44%11.33%-23.13%
Net Income Per EBT
80.35%74.31%173.35%92.44%140.36%
EBT Per EBIT
101.48%90.30%87.10%54.48%-1004.46%
Return on Assets (ROA)
16.33%15.88%26.93%7.98%-12.14%
Return on Equity (ROE)
26.32%27.59%45.05%18.55%-53.36%
Return on Capital Employed (ROCE)
23.91%29.65%20.20%18.10%1.26%
Return on Invested Capital (ROIC)
21.25%21.53%34.90%16.64%1.76%
Return on Tangible Assets
17.97%19.11%35.38%11.95%-19.59%
Earnings Yield
8.53%6.71%5.57%1.41%-2.52%
Efficiency Ratios
Receivables Turnover
8.31 7.85 8.00 8.77 7.20
Payables Turnover
5.91 6.84 22.05 55.46 10.85
Inventory Turnover
27.43 22.61 19.43 12.53 7.26
Fixed Asset Turnover
561.43 1.57K 764.14 372.49 170.30
Asset Turnover
0.70 0.72 0.65 0.70 0.37
Working Capital Turnover Ratio
1.58 1.91 1.59 1.70 2.28
Cash Conversion Cycle
-4.50 9.26 47.87 64.19 67.34
Days of Sales Outstanding
43.93 46.49 45.63 41.64 50.67
Days of Inventory Outstanding
13.31 16.15 18.79 29.14 50.31
Days of Payables Outstanding
61.73 53.38 16.55 6.58 33.63
Operating Cycle
57.24 62.64 64.42 70.78 100.98
Cash Flow Ratios
Operating Cash Flow Per Share
4.51 3.69 2.44 1.71 -0.05
Free Cash Flow Per Share
4.50 3.68 1.76 -0.03 -0.09
CapEx Per Share
0.01 <0.01 0.68 1.74 0.04
Free Cash Flow to Operating Cash Flow
1.00 1.00 0.72 -0.02 1.67
Dividend Paid and CapEx Coverage Ratio
400.27 703.16 3.60 0.98 -1.49
Capital Expenditure Coverage Ratio
400.27 703.16 3.60 0.98 -1.49
Operating Cash Flow Coverage Ratio
1.51 1.13 0.75 0.51 -0.02
Operating Cash Flow to Sales Ratio
0.34 0.38 0.33 0.32 -0.02
Free Cash Flow Yield
12.19%11.40%3.20%-0.07%-0.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.72 14.91 17.97 70.91 -39.66
Price-to-Sales (P/S) Ratio
2.75 3.30 7.45 8.03 12.87
Price-to-Book (P/B) Ratio
2.74 4.11 8.09 13.15 21.16
Price-to-Free Cash Flow (P/FCF) Ratio
8.20 8.77 31.26 -1.41K -412.39
Price-to-Operating Cash Flow Ratio
8.17 8.76 22.57 24.89 -688.98
Price-to-Earnings Growth (PEG) Ratio
0.64 -0.51 0.04 -0.43 0.63
Price-to-Fair Value
2.74 4.11 8.09 13.15 21.16
Enterprise Value Multiple
6.60 8.14 22.35 22.66 1.34K
Enterprise Value
1.75B 1.80B 3.21B 2.41B 2.02B
EV to EBITDA
6.60 8.14 22.35 22.66 1.34K
EV to Sales
2.26 3.10 7.33 7.89 12.66
EV to Free Cash Flow
6.76 8.23 30.76 -1.38K -405.50
EV to Operating Cash Flow
6.74 8.22 22.21 24.46 -677.46
Tangible Book Value Per Share
13.45 5.55 4.09 0.74 -1.15
Shareholders’ Equity Per Share
13.45 7.85 6.81 3.24 1.71
Tax and Other Ratios
Effective Tax Rate
0.09 0.26 -0.73 0.08 -0.40
Revenue Per Share
13.44 9.79 7.40 5.31 2.81
Net Income Per Share
3.15 2.17 3.07 0.60 -0.91
Tax Burden
0.80 0.74 1.73 0.92 1.40
Interest Burden
0.93 0.88 0.87 0.61 -2.17
Research & Development to Revenue
0.19 0.13 0.16 0.10 0.12
SG&A to Revenue
0.16 0.16 0.19 0.21 0.25
Stock-Based Compensation to Revenue
0.06 0.05 0.06 0.05 0.03
Income Quality
1.43 1.70 0.80 2.85 0.08
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis